Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Comment by Kusanationon Nov 13, 2020 10:32am
155 Views
Post# 31894664

RE:RE:Feeling

RE:RE:FeelingId have to disagree with you. The reason being is because should the data been questionable to the extent of rejection then we would have seen that already. You almost need to look at the longer wait as a good thing when it comes to decisions being made and I will explain why. Think of it like a criminal case and jury having to come up with a verdict. If you ask any defence lawyer, they will tell you that the longer the jury takes to deliberate, the more likely it means they are looking into it with more detail and thus giving you a chance. On the other hand, if the jury comes back quick with a response, it means they already have the majority of their mind made up after hearing the details in court and just need to follow producure of "deliberating" before they can submit their verdict. A same scenario is being played out here. The jury (HC) is reviewing the data (evidence of the case), it seems like there is potential to grant the defendent (SONA) a good deal but they need to be sure before they give their verdict (aprroval) because they dont want any backlash from the public (failure of product when out in the market) due to thier decision. 

Thats my two cents, you dont have to agree. But, typically speaking the fact that they keep changing the status during its review process is an indication that HC is considering it but needs to be sure of specific elements (could be data or manufacturing capacity). 

Give this bad boy a thums up if you agree. 
<< Previous
Bullboard Posts
Next >>